Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.

Abstract

Objective When patients take neuroleptics, the distinction between Parkinson's disease (PD) and drug-induced parkinsonism (DIP) based solely on clinical features can become difficult. At present, 123I-FP-CIT SPECT (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy are widely used to supplement the differential diagnosis of parkinsonism. This study assessed the clinical symptoms and neurological findings in the patients suspected of having DIP based on DAT-SPECT findings. Methods Twenty-three patients (11 men, 12 women, age: 52-81 years old) presenting with DIP were recruited. All patients underwent neurological examinations, including brain magnetic resonance imaging and DAT-SPECT. Patients who showed abnormal DAT-SPECT results underwent MIBG myocardial scintigraphy. Results Eleven patients showed a reduction in the ligand uptake on DAT-SPECT (DAT-positive group), and nine of these patients showed a low delayed heart-to-mediastinum (H/M) ratio on MIBG myocardial scintigraphy. The remaining 12 patients showed normal results on DAT-SPECT (DAT-negative group). All patients in the DAT-positive group had asymmetric motor symptoms, whereas only 4 in the DAT-negative group exhibited this clinical feature (p=0.001). A detailed medical history showed that 7 of the 11 patients in the DAT-positive group had prodromal symptoms for PD. However, only 1 patient in the DAT-negative group exhibited these symptoms (p= 0.009). Although two patients in the DAT-negative group showed poor improvement, they showed a normal H/M ratio on MIBG and no response to levodopa. Conclusion The patients in the DAT-positive group might have prodromal symptoms that were worsened by neuroleptic drugs. The results of detailed history-taking and neurological findings seem to indicate cases of compromised dopaminergic transmission before the administration of neuroleptic drugs.

• Authors: Kei Tachibana, Keita Matsuura, Akihiro Shindo, Hirofumi Matsuyama, Yuichiro Ii, Akira Taniguchi, Hidekazu Tomimoto
• Journal: Internal medicine (Tokyo, Japan) (Intern Med) Vol. 59 Issue 4 Pg. 485-490 ( 2020) ISSN: 1349-7235 [Electronic] Japan
• PMID: 32062624 (Publication Type: Journal Article)

Chemical References

• Antipsychotic Agents

Topics

• Aged
• Aged, 80 and over
• Antipsychotic Agents (adverse effects)
• Diagnosis, Differential
• Female
• Functional Neuroimaging (methods)
• Humans
• Male
• Middle Aged
• Parkinson Disease (diagnostic imaging)
• Parkinson Disease, Secondary (chemically induced)
• Parkinsonian Disorders (chemically induced, diagnostic imaging)
• Symptom Assessment